Completed Purchases, Ratings Upgrade, Results Presentation, Dividend Declaration, and Conference Participation - Research Report on NHI, HTA, AmerisourceBergen, Questcor, and Thoratec Editor Note: For more information about this release, please scroll to bottom. PR Newswire NEW YORK, December 31, 2013 NEW YORK, December 31, 2013 /PRNewswire/ -- Today, Analysts' Corner announced new research reports highlighting National Health Investors, Inc. (NYSE: NHI), Healthcare Trust of America, Inc. (NYSE: HTA), AmerisourceBergen Corporation (NYSE: ABC), Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR), and Thoratec Corporation (NASDAQ: THOR). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below. National Health Investors, Inc. Research Report On December 23, 2013, National Health Investors, Inc. (NHI) announced the completion of its previously announced purchase of 25 independent living facilities from Holliday Acquisition Holdings LLC, an affiliate of Holiday Retirement. NHI reported that the purchase price was $491 million plus transaction costs. NHI informed that the facilities will continue to be operated by affiliates of Holiday Retirement, pursuant to a new 17-year master lease. "The acquisition of these 25 independent living communities provides substantial geographic, asset class and operator diversification on a very accretive basis. We were able to conservatively fund the acquisition with strong execution on the equity offering and better-than-expected pricing on our new term loan tranche. These transactions will be instrumental in supporting our growth in 2014," said Justin Hutchens, CEO and President of NHI. The Full Research Report on National Health Investors, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: http://www.analystscorner.com/r/full_research_report/9fd4_NHI -- Healthcare Trust of America, Inc. Research Report On December 19, 2013, Healthcare Trust of America, Inc. (HTA) announced that Moody's Investors Services (Moody's) has upgraded the Company's investment grade credit rating to Baa2, with a stable outlook. The Company reported that Moody's ratings upgrade was based on HTA's high quality on-campus medical office building portfolio, low leverage profile, and successful execution of its recent growth strategy. The Full Research Report on Healthcare Trust of America, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: http://www.analystscorner.com/r/full_research_report/1100_HTA -- AmerisourceBergen Corporation Research Report On December 20, 2013, AmerisourceBergen Corporation (AmerisourceBergen) announced that it will release its Q1 2014 results on January 23, 2014, before the opening of trading on the NYSE. The Company informed that it will host a conference call at 11:00 a.m. ET, on the same day, to discuss the results. The Full Research Report on AmerisourceBergen Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: http://www.analystscorner.com/r/full_research_report/29fb_ABC -- Questcor Pharmaceuticals, Inc. Research Report On December 11, 2013, Questcor Pharmaceuticals, Inc. (Questcor) announced that its Board of Directors has declared a quarterly cash dividend of $0.30 per share, or $1.20 per share on an annual basis. The dividend is payable on or about January 24, 2014, to shareholders of record at the close of business on January 17, 2014. In addition, the Company also announced that it has made open market share purchases during Q4 2013 of approximately 0.5 million shares of Questcor common stock through December 10, 2013. Questcor informed that the shares were purchased at an average price of $57.21 per share. The Full Research Report on Questcor Pharmaceuticals, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: http://www.analystscorner.com/r/full_research_report/a415_QCOR -- Thoratec Corporation Research Report On December 19, 2013, Thoratec Corporation (Thoratec) announced participation in the 32^nd Annual J.P. Morgan Healthcare Conference on January 13, 2014. The Company reported that Gary F. Burbach, President and CEO of Thoratec, is scheduled to provide an update on the Company at 8:00 a.m. PST / 11:00 a.m. EST. The Full Research Report on Thoratec Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: http://www.analystscorner.com/r/full_research_report/1bee_THOR ---- EDITOR NOTES: 1.This is not company news. We are an independent source and our views do not reflect the companies mentioned. 2.Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. 3.This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public. 4.If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com. 5.For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com. 6.Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration. COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be. NOT FINANCIAL ADVICE Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein. NO WARRANTY OR LIABILITY ASSUMED Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute. AnalystsCorner.com SOURCE Analysts' Corner Contact: Joe Thomas, CONTACT PHONE: +1-310-496-8071 (North America)
Completed Purchases, Ratings Upgrade, Results Presentation, Dividend Declaration, and Conference Participation - Research Report
Press spacebar to pause and continue. Press esc to stop.